Literature DB >> 18645031

Key role for Bak activation and Bak-Bax interaction in the apoptotic response to vinblastine.

Meenakshi Upreti1, Rong Chu, Elena Galitovskaya, Sherri K Smart, Timothy C Chambers.   

Abstract

Microtubule inhibitors such as vinblastine cause mitotic arrest and subsequent apoptosis through the intrinsic mitochondrial pathway. However, although Bcl-2 family proteins have been implicated as distal mediators, their precise role is largely unknown. In this study, we investigated the role of Bak in vinblastine-induced apoptosis. Bak was mainly monomeric in untreated KB-3 cells, and multimers corresponding to dimer, trimer, and higher oligomers were observed after vinblastine treatment. The oligomeric Bak species were strongly diminished in cells stably overexpressing Bcl-xL. Immunoprecipitation with a conformation-dependent Bak antibody revealed that vinblastine induced Bak activation. Reciprocal immunoprecipitations indicated that vinblastine induced the interaction of active Bak with active Bax. Furthermore, Bcl-xL overexpression prevented Bak and Bax interaction and strongly inhibited apoptosis, whereas Bcl-2 overexpression did not prevent Bak-Bax interaction and only weakly inhibited apoptosis. The relative contributions of Bak and Bax were investigated using fibroblasts deficient in one or both of these proteins; double knockouts were highly resistant compared with single knockouts, with vinblastine sensitivities in the order of Bak(+)/Bax(+) > Bak(+)/Bax(-) > Bak(-)/Bax(+) > Bak(-)/Bax(-). These results highlight Bak as a key mediator of vinblastine-induced apoptosis and show for the first time activation and oligomerization of Bak by an antimitotic agent. In addition, our results suggest that the interaction of the activated forms of Bak and Bax represents a key distal step in the apoptotic response to this important chemotherapeutic drug.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18645031      PMCID: PMC3276366          DOI: 10.1158/1535-7163.MCT-07-2299

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  34 in total

Review 1.  Mitochondrial control of cell death.

Authors:  G Kroemer; J C Reed
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

Review 2.  Mitochondrial fission in apoptosis.

Authors:  Richard J Youle; Mariusz Karbowski
Journal:  Nat Rev Mol Cell Biol       Date:  2005-08       Impact factor: 94.444

3.  Unraveling MCL-1 degradation.

Authors:  J T Opferman
Journal:  Cell Death Differ       Date:  2006-05-19       Impact factor: 15.828

Review 4.  How do Bax and Bak lead to permeabilization of the outer mitochondrial membrane?

Authors:  Antonella Antignani; Richard J Youle
Journal:  Curr Opin Cell Biol       Date:  2006-10-12       Impact factor: 8.382

Review 5.  The Bcl-2 apoptotic switch in cancer development and therapy.

Authors:  J M Adams; S Cory
Journal:  Oncogene       Date:  2007-02-26       Impact factor: 9.867

6.  Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak.

Authors:  Simon N Willis; Jamie I Fletcher; Thomas Kaufmann; Mark F van Delft; Lin Chen; Peter E Czabotar; Helen Ierino; Erinna F Lee; W Douglas Fairlie; Philippe Bouillet; Andreas Strasser; Ruth M Kluck; Jerry M Adams; David C S Huang
Journal:  Science       Date:  2007-02-09       Impact factor: 47.728

7.  The multidomain proapoptotic molecules Bax and Bak are directly activated by heat.

Authors:  Lisa J Pagliari; Tomomi Kuwana; Christine Bonzon; Donald D Newmeyer; Shine Tu; Helen M Beere; Douglas R Green
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

8.  tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c.

Authors:  M C Wei; T Lindsten; V K Mootha; S Weiler; A Gross; M Ashiya; C B Thompson; S J Korsmeyer
Journal:  Genes Dev       Date:  2000-08-15       Impact factor: 11.361

9.  Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins.

Authors:  Simon N Willis; Lin Chen; Grant Dewson; Andrew Wei; Edwina Naik; Jamie I Fletcher; Jerry M Adams; David C S Huang
Journal:  Genes Dev       Date:  2005-05-18       Impact factor: 11.361

Review 10.  BCL-2 in the crosshairs: tipping the balance of life and death.

Authors:  L D Walensky
Journal:  Cell Death Differ       Date:  2006-06-09       Impact factor: 15.828

View more
  20 in total

1.  PTEN induces apoptosis and cavitation via HIF-2-dependent Bnip3 upregulation during epithelial lumen formation.

Authors:  Y Qi; J Liu; S Saadat; X Tian; Y Han; G-H Fong; P P Pandolfi; L Y Lee; S Li
Journal:  Cell Death Differ       Date:  2014-11-14       Impact factor: 15.828

2.  The combination of thioxodihydroquinazolinones and platinum drugs reverses platinum resistance in tumor cells by inducing mitochondrial apoptosis independent of Bax and Bak.

Authors:  Wei Qian; Joseph Salamoun; Jingnan Wang; Vera Roginskaya; Bennett Van Houten; Peter Wipf
Journal:  Bioorg Med Chem Lett       Date:  2014-12-30       Impact factor: 2.823

3.  Pim kinase inhibitors sensitize prostate cancer cells to apoptosis triggered by Bcl-2 family inhibitor ABT-737.

Authors:  Jin H Song; Andrew S Kraft
Journal:  Cancer Res       Date:  2011-11-11       Impact factor: 12.701

4.  Apoptotic effect of hot water extract of Sanguisorba officinalis L. in human oral cancer cells.

Authors:  Ji-Ae Shin; Jun-Sung Kim; Ki-Han Kwon; Jeong-Seok Nam; Ji-Youn Jung; Nam-Pyo Cho; Sung-Dae Cho
Journal:  Oncol Lett       Date:  2012-06-08       Impact factor: 2.967

5.  Cdk1/cyclin B plays a key role in mitotic arrest-induced apoptosis by phosphorylation of Mcl-1, promoting its degradation and freeing Bak from sequestration.

Authors:  Rong Chu; David T Terrano; Timothy C Chambers
Journal:  Biochem Pharmacol       Date:  2011-10-18       Impact factor: 5.858

Review 6.  Microtubule destabilising agents: far more than just antimitotic anticancer drugs.

Authors:  Darcy Bates; Alan Eastman
Journal:  Br J Clin Pharmacol       Date:  2016-10-18       Impact factor: 4.335

7.  Cisplatin-induced apoptosis in p53-deficient renal cells via the intrinsic mitochondrial pathway.

Authors:  Man Jiang; Cong-Yi Wang; Shuang Huang; Tianxin Yang; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2009-03-11

8.  Chemopreventive agent 3,3'-diindolylmethane selectively induces proteasomal degradation of class I histone deacetylases.

Authors:  Yongming Li; Xia Li; Bin Guo
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

9.  Pegylated IFN-α sensitizes melanoma cells to chemotherapy and causes premature senescence in endothelial cells by IRF-1 mediated signaling.

Authors:  M Upreti; N A Koonce; L Hennings; T C Chambers; R J Griffin
Journal:  Cell Death Dis       Date:  2010       Impact factor: 8.469

10.  Paclitaxel-induced apoptosis is BAK-dependent, but BAX and BIM-independent in breast tumor.

Authors:  Anna V Miller; Mark A Hicks; Wataru Nakajima; Amanda C Richardson; Jolene J Windle; Hisashi Harada
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.